Spots Global Cancer Trial Database for URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol
Official Title: Urinary VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence
Study ID: NCT00392548
Conditions
Interventions
Study Description
Brief Summary: Study of the urinary vascular endothelial growth factor (VEGF) levels in patients with glioblastoma, receiving standard therapy. Hypothesis: that urinary VEGF levels can serve as a predictor of treatment response and survival.
Detailed Description: Measurement of urinary VEGF levels pre treatment,immediately after treatment, and 1 month after treatment
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
tel Aviv Sourasky Medical Center, Tel Aviv, , Israel
Contact Details
Name: Deborah T Blumenthal, MD
Affiliation: Tel-Aviv Sourasky Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
